Tofacitinib Citrate 100 mg | ≥99% LKT Laboratories, Inc. JAK1/2/3 inhibitor. More Information Supplier Page × Tofacitinib Citrate
Tofacitinib Citrate 25 mg | ≥99% LKT Laboratories, Inc. JAK1/2/3 inhibitor. More Information Supplier Page × Tofacitinib Citrate
Tofacitinib Citrate 5 mg | ≥99% LKT Laboratories, Inc. JAK1/2/3 inhibitor. More Information Supplier Page × Tofacitinib Citrate
MLN-2238 10 mg | ≥99% LKT Laboratories, Inc. Proteasome inhibitor, miR33b modulator. More Information Supplier Page × MLN-2238
MLN-2238 5 mg | ≥99% LKT Laboratories, Inc. Proteasome inhibitor, miR33b modulator. More Information Supplier Page × MLN-2238
Borrelidin 5 mg | ≥99% LKT Laboratories, Inc. Macrolide; threonyl-tRNA synthetase/ligase inhibitor. More Information Supplier Page × Borrelidin
3-tert-Butyl-4-Hydroxyanisole 5 g | ≥99% LKT Laboratories, Inc. BHA derivative, antioxidative food and cosmetics additive. More Information Supplier Page × 3-tert-Butyl-4-Hydroxyanisole
Triclosan Methyl Ether 25 mg | ≥99% LKT Laboratories, Inc. Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor. More Information Supplier Page × Triclosan Methyl Ether
Cetirizine Dihydrochloride 1 g | ≥99% LKT Laboratories, Inc. Histamine H1 antagonist. More Information Supplier Page × Cetirizine Dihydrochloride
8-Gingerol 25 mg | ≥99% LKT Laboratories, Inc. Phenol found in Zingiber; 5-HT3 antagonist. More Information Supplier Page × 8-Gingerol
